Communiqués Spectral AI, Inc.

Actions

MDAI

US84757T1051

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 07/10/2026			Varia. 5j.	Varia. 1 janv.
1,640 ^USD	-1,20 %		+3,80 %	+15,49 %

06/10	Spectral AI, Inc. soumet une demande de paiement complémentaire au titre des nouvelles technologies pour le système DeepView	CI
01/10	Spectral AI annonce la réalisation de la première visite d’initiation du centre pour l’étude clinique du système DeepView, dans le cadre de sa stratégie d’extension de l’indication aux brûlures de la tête, des mains et des pieds	CI

Communiqués

16:09	Spectral AI Submits New Technology Add-On Payment Application for DeepView System	AQ
06/10	Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System	GL
01/10	Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet	GL
24/09	Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds	GL
16/09	Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference	GL
01/09	Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference	GL
11/08	Spectral AI Announces 2026 Second Quarter Financial Results	GL
29/07	Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call	GL
08/07	Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication	GL
25/06	DeepView® System Highlighted at the 2026 British Burn Association Annual Conference	GL
12/06	Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month	GL
11/06	Spectral AI to Participate in 2026 British Burn Association Annual Conference	GL
01/06	Spectral AI Announces Voting Results of Annual Meeting of Stockholders	GL
26/05	Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication	GL
26/05	Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication	AQ
12/05	Spectral AI Announces 2026 First Quarter Financial Results	GL
12/05	Spectral AI Announces 2026 First Quarter Financial Results	AQ
30/04	Spectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation Conference	GL
28/04	Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call	GL
22/04	Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting	GL
20/04	Spectral AI Announces Annual Meeting of Stockholders	GL
10/04	Spectral AI to Feature DeepView System at 2026 American Burn Association Annual Meeting	AQ
09/04	Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting	GL
08/04	Spectral AI Names David McGuire, CPA, as Chief Financial Officer	GL
24/03	Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026	GL